SGHEALTHCARE CO.,LTD.

398120 KRX Technology Technology
KOSDAQ
₩1,780.00
+1.14%
Delayed · cached 15 min

Fair value analysis

398120
SGHEALTHCARE CO.,LTD.
TechnologyTechnology
₩1,780.00
Close used for this calculation
₩1,523.18Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
26/100
Profitability4/25
Returns5/25
Balance Sheet13/25
Efficiency4/25
Growth0/25
Weak
Quality radar
26Prof.4/25Ret.5/25Eff.4/25B.Sht13/25Growth0/25

Consensus fair value

₩1,523.18
Near FV
▼ -14.4% against the close used
Model range ₩282.20 – ₩2,049.48
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩282.20Fair value₩1,523.18Bull₩2,049.48
FairClose
52-week traded range
52W low ₩1,674.0052W high ₩4,500.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

SGHEALTHCARE CO.,LTD. closed at ₩1,780.00, 16.9% above the consensus fair value of ₩1,523.18 drawn from 7 valuation models.

Financial DNA score 26/100 — Weak. P/E of 20.7x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₩1,611.86
-9.4%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
₩2,049.48
+15.1%
√(22.5 × EPS × BVPS)
EPS=86, BVPS=2170.73
P/E Fair Value
₩1,720.00
-3.4%
EPS × 20x (sector P/E)
EPS=86, Sector P/E=20x
EV/EBITDA
₩966.37
-45.7%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=1.47B
Book Value (P/B)
₩282.20
-84.1%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=2170.73, ROE=3.9%, g=3%, r=10%
Reverse DCF
₩1,780.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 7.6% | Historical: 0%
Margin of Safety
₩1,345.34
-24.4%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=1793.78, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.